1. Alternative procedures for blood and blood components during the COVID-19 public health emergency Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, April 2020 Subject(s): Blood DonorsBlood TransfusionPlasmaCOVID-19United StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
2. Investigational COVID-19 convalescent plasma Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, February 11, 2021 Subject(s): Antibodies, ViralBlood DonorsCOVID-19 -- therapyPlasmaUnited StatesUnited States. Department of Health and Human Services.United States. Food and Drug Administration.
3. Compliance policy regarding blood and blood component donation suitability, donor eligibility and source plasma quarantine hold requirements: guidance for industry Publication: Silver Spring, MD : Center for Biologics Evaluation and Research, October 2023 Subject(s): Blood Banking -- standardsBlood Donation -- standardsBlood DonorsDonor Selection -- standardsGovernment RegulationGuideline AdherencePlasmaUnited States
